Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18047832rdf:typepubmed:Citationlld:pubmed
pubmed-article:18047832lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:18047832lifeskim:mentionsumls-concept:C0870134lld:lifeskim
pubmed-article:18047832lifeskim:mentionsumls-concept:C0225828lld:lifeskim
pubmed-article:18047832lifeskim:mentionsumls-concept:C0521324lld:lifeskim
pubmed-article:18047832lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:18047832lifeskim:mentionsumls-concept:C0040690lld:lifeskim
pubmed-article:18047832lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:18047832pubmed:issue4lld:pubmed
pubmed-article:18047832pubmed:dateCreated2007-12-17lld:pubmed
pubmed-article:18047832pubmed:abstractTextThe existence of skeletal muscle-derived stem cells (MDSCs) has been suggested in mammals; however, the signaling pathways controlling MDSC proliferation remain largely unknown. Here we report the isolation of myosphere-derived progenitor cells (MDPCs) that can give rise to beating cardiomyocytes from adult skeletal muscle. We identified that follistatin, an antagonist of TGF-beta family members, was predominantly expressed in MDPCs, whereas myostatin was mainly expressed in myogenic cells and mature skeletal muscle. Although follistatin enhanced the replicative growth of MDPCs through Smad2/3 inactivation and cell cycle progression, disruption of myostatin did not increase the MDPC proliferation. By contrast, inhibition of activin A (ActA) or growth differentiation factor 11 (GDF11) signaling dramatically increased MDPC proliferation via down-regulation of p21 and increases in the levels of cdk2/4 and cyclin D1. Thus, follistatin may be an effective progenitor-enhancing agent neutralizing ActA and GDF11 signaling to regulate the growth of MDPCs in skeletal muscle.lld:pubmed
pubmed-article:18047832pubmed:languageenglld:pubmed
pubmed-article:18047832pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18047832pubmed:citationSubsetIMlld:pubmed
pubmed-article:18047832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18047832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18047832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18047832pubmed:statusMEDLINElld:pubmed
pubmed-article:18047832pubmed:monthJanlld:pubmed
pubmed-article:18047832pubmed:issn1090-2104lld:pubmed
pubmed-article:18047832pubmed:authorpubmed-author:TakahashiTomo...lld:pubmed
pubmed-article:18047832pubmed:authorpubmed-author:MatsubaraHiro...lld:pubmed
pubmed-article:18047832pubmed:authorpubmed-author:AshiharaEishi...lld:pubmed
pubmed-article:18047832pubmed:authorpubmed-author:OhHidemasaHlld:pubmed
pubmed-article:18047832pubmed:authorpubmed-author:UeyamaTomomiTlld:pubmed
pubmed-article:18047832pubmed:authorpubmed-author:AsadaSatoshiSlld:pubmed
pubmed-article:18047832pubmed:authorpubmed-author:NakajimaNorio...lld:pubmed
pubmed-article:18047832pubmed:authorpubmed-author:NomuraTetsuya...lld:pubmed
pubmed-article:18047832pubmed:authorpubmed-author:TateishiKento...lld:pubmed
pubmed-article:18047832pubmed:authorpubmed-author:IsodonoKojiKlld:pubmed
pubmed-article:18047832pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18047832pubmed:day25lld:pubmed
pubmed-article:18047832pubmed:volume365lld:pubmed
pubmed-article:18047832pubmed:ownerNLMlld:pubmed
pubmed-article:18047832pubmed:authorsCompleteYlld:pubmed
pubmed-article:18047832pubmed:pagination863-9lld:pubmed
pubmed-article:18047832pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:meshHeadingpubmed-meshheading:18047832...lld:pubmed
pubmed-article:18047832pubmed:year2008lld:pubmed
pubmed-article:18047832pubmed:articleTitleSkeletal muscle-derived progenitors capable of differentiating into cardiomyocytes proliferate through myostatin-independent TGF-beta family signaling.lld:pubmed
pubmed-article:18047832pubmed:affiliationDepartment of Experimental Therapeutics, Translational Research Center, Kyoto University Hospital, Kyoto 606-8507, Japan.lld:pubmed
pubmed-article:18047832pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18047832pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:14313entrezgene:pubmedpubmed-article:18047832lld:entrezgene
entrez-gene:21803entrezgene:pubmedpubmed-article:18047832lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18047832lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18047832lld:pubmed